D.E. Shaw & Co’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,078
| Closed | -$91K | – | 4142 |
|
|
2021
Q2 | $91K | Sell |
11,078
-52,563
| -83% | -$432K | ﹤0.01% | 3353 |
|
|
2021
Q1 | $570K | Sell |
63,641
-14,773
| -19% | -$132K | ﹤0.01% | 2451 |
|
|
2020
Q4 | $905K | Sell |
78,414
-158,596
| -67% | -$1.83M | ﹤0.01% | 2063 |
|
|
2020
Q3 | $2.47M | Sell |
237,010
-466,669
| -66% | -$4.86M | ﹤0.01% | 1537 |
|
|
2020
Q2 | $9.25M | Buy |
703,679
+250,185
| +55% | +$3.29M | 0.01% | 889 |
|
|
2020
Q1 | $3.57M | Buy |
453,494
+132,787
| +41% | +$1.05M | 0.01% | 1229 |
|
|
2019
Q4 | $6.64M | Sell |
320,707
-300,236
| -48% | -$6.22M | 0.01% | 1043 |
|
|
2019
Q3 | $8.51M | Buy |
620,943
+75,886
| +14% | +$1.04M | 0.01% | 902 |
|
|
2019
Q2 | $6.7M | Buy |
545,057
+90,204
| +20% | +$1.11M | 0.01% | 1030 |
|
|
2019
Q1 | $5.68M | Buy |
454,853
+204,451
| +82% | +$2.55M | 0.01% | 1095 |
|
|
2018
Q4 | $2.84M | Buy |
250,402
+209,809
| +517% | +$2.38M | ﹤0.01% | 1354 |
|
|
2018
Q3 | $759K | Sell |
40,593
-25,906
| -39% | -$484K | ﹤0.01% | 1919 |
|
|
2018
Q2 | $1.72M | Buy |
+66,499
| New | +$1.72M | ﹤0.01% | 1675 |
|
|
2017
Q4 | – | Sell |
-105,458
| Closed | -$2.55M | – | 2705 |
|
|
2017
Q3 | $2.55M | Buy |
105,458
+69,401
| +192% | +$1.68M | ﹤0.01% | 1354 |
|
|
2017
Q2 | $729K | Sell |
36,057
-19,248
| -35% | -$389K | ﹤0.01% | 1849 |
|
|
2017
Q1 | $1.49M | Buy |
55,305
+33,205
| +150% | +$893K | ﹤0.01% | 1514 |
|
|
2016
Q4 | $420K | Buy |
+22,100
| New | +$420K | ﹤0.01% | 2098 |
|
|
2016
Q2 | – | Sell |
-92,815
| Closed | -$854K | – | 2743 |
|
|
2016
Q1 | $854K | Buy |
92,815
+66,060
| +247% | +$608K | ﹤0.01% | 1824 |
|
|
2015
Q4 | $516K | Sell |
26,755
-24,170
| -47% | -$466K | ﹤0.01% | 2062 |
|
|
2015
Q3 | $757K | Buy |
+50,925
| New | +$757K | ﹤0.01% | 1857 |
|